8-K
Current Report
Cartesian Therapeutics, Inc. Filed Acc 0001453687-17-000056
Material agreement · Agreement ended · New debt or obligation · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading selectabiosciences8k_ventu.htm…